LUNG Pulmonx Corp
Nasdaq · SEC CIK 1127537 · EDGAR
- Bought, last 12 months
- $0 0 purchases by 0 insiders
- Sold, last 12 months
- $547.9K 16 sales by 5 insiders
- Filings on record
- 173 since 2021-07-13, latest 2026-09-03 18:23
BoughtSold
Most active insiders, 12 months
| Insider | Title | Bought | Sold |
|---|---|---|---|
| French Glendon E. III | Pres, CEO, Dir | — | $292.3K |
| Lehman David Aaron | GC | — | $88.5K |
| Radhakrishnan Srikanth | Chief Science, Techn. Off | — | $69.5K |
| Rose Geoffrey Beran | Chief Commercial Off | — | $51.1K |
| Florin Daniel P | Dir | — | $46.4K |
| Sullivan Tiffany | Dir | — | — |
| Melenikiotou Georgia | Dir | — | — |
| Sung Derrick | COO, CFO | — | — |
| Burns Thomas William | Dir | — | — |
| Mead Dana G Jr. | Dir | — | — |
Transactions 199
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| M | 2026-09-03 18:23 | 2026-09-01 | LUNG | French Glendon E. III | Pres, CEO, Dir | S - Sale | $2.26 | -41.9K | 1.14M | -4% | -$94.7K |
| M | 2026-09-03 18:21 | 2026-09-01 | LUNG | Radhakrishnan Srikanth | Chief Science, Techn. Off | S - Sale | $2.26 | -14.2K | 317.0K | -4% | -$32.2K |
| M | 2026-09-03 18:19 | 2026-09-01 | LUNG | Lehman David Aaron | GC | S - Sale | $2.26 | -14.3K | 361.8K | -4% | -$32.4K |
| M | 2026-09-03 18:17 | 2026-09-01 | LUNG | Rose Geoffrey Beran | Chief Commercial Off | S - Sale | $2.26 | -7,879 | 449.8K | -2% | -$17.8K |
| 2026-06-09 18:02 | 2026-06-05 | LUNG | Burns Thomas William | Dir | A - Grant | $0.00 | +40.0K | 113.4K | +54% | $0 | |
| 2026-06-09 18:01 | 2026-06-05 | LUNG | Ferrari Richard | Dir | A - Grant | $0.00 | +40.0K | 127.0K | +46% | $0 | |
| 2026-06-09 17:59 | 2026-06-05 | LUNG | Florin Daniel P | Dir | A - Grant | $0.00 | +40.0K | 133.9K | +43% | $0 | |
| 2026-06-09 17:56 | 2026-06-05 | LUNG | Melenikiotou Georgia | Dir | A - Grant | $0.00 | +40.0K | 139.7K | +40% | $0 | |
| 2026-06-09 17:54 | 2026-06-05 | LUNG | Sullivan Tiffany | Dir | A - Grant | $0.00 | +40.0K | 115.2K | +53% | $0 | |
| 2026-06-09 17:49 | 2026-06-05 | LUNG | Mead Dana G Jr. | Dir | A - Grant | $0.00 | +40.0K | 139.7K | +40% | $0 | |
| M | 2026-06-03 16:18 | 2026-06-01 | LUNG | Radhakrishnan Srikanth | Chief Science, Techn. Off | S - Sale | $1.54 | -14.5K | 331.2K | -4% | -$22.3K |
| M | 2026-06-03 16:17 | 2026-06-01 | LUNG | Lehman David Aaron | GC | S - Sale | $1.54 | -14.6K | 376.2K | -4% | -$22.5K |
| M | 2026-06-03 16:16 | 2026-06-01 | LUNG | Rose Geoffrey Beran | Chief COMMERCIAL Off | S - Sale | $1.54 | -8,023 | 457.7K | -2% | -$12.4K |
| M | 2026-06-03 16:15 | 2026-06-01+ | LUNG | French Glendon E. III | Pres, CEO, Dir | S - Sale | $1.55 | -56.1K | 1.18M | -5% | -$86.9K |
| M | 2026-03-04 | 2026-03-02 | LUNG | French Glendon E. III | Pres, CEO, Dir | S - Sale | $1.43 | -67.8K | 1.47M | -4% | -$97.0K |
| M | 2026-03-04 | 2026-03-02 | LUNG | Rose Geoffrey Beran | Chief COMMERCIAL Off | S - Sale | $1.43 | -7,732 | 368.6K | -2% | -$11.1K |
| 2026-03-04 | 2026-03-02 | LUNG | Rose Geoffrey Beran | Chief COMMERCIAL Off | A - Grant | $0.00 | +100.0K | 465.7K | +27% | $0 | |
| M | 2026-03-04 | 2026-03-02 | LUNG | Radhakrishnan Srikanth | Chief Science, Techn. Off | S - Sale | $1.43 | -10.5K | 177.4K | -6% | -$15.0K |
| 2026-03-04 | 2026-03-02 | LUNG | Radhakrishnan Srikanth | Chief Science, Techn. Off | A - Grant | $0.00 | +175.0K | 345.7K | +102% | $0 | |
| M | 2026-03-04 | 2026-03-02 | LUNG | Lehman David Aaron | GC | S - Sale | $1.43 | -12.2K | 244.8K | -5% | -$17.5K |
| 2026-03-04 | 2026-03-02 | LUNG | Lehman David Aaron | GC | A - Grant | $0.00 | +150.0K | 390.8K | +62% | $0 | |
| 2025-12-09 | 2025-12-08 | LUNG | Florin Daniel P | Dir | S - Sale | $1.99 | -23.3K | 93.9K | -20% | -$46.4K | |
| M | 2025-12-03 | 2025-12-01 | LUNG | Rose Geoffrey Beran | Chief COMMERCIAL Off | S - Sale | $1.57 | -6,322 | 373.5K | -2% | -$9,926 |
| M | 2025-12-03 | 2025-12-01 | LUNG | Lehman David Aaron | GC | S - Sale | $1.57 | -10.3K | 253.0K | -4% | -$16.1K |
| DM | 2025-12-03 | 2025-12-01 | LUNG | French Glendon E. III | Pres, CEO, Dir | S - Sale | $1.57 | -8,805 | 277.3K | -3% | -$13.8K |
| D | 2025-12-03 | 2025-12-01 | LUNG | French Glendon E. III | Pres, CEO, Dir | A - Grant | $0.00 | +1.20M | 1.48M | +433% | $0 |
| D | 2025-12-03 | 2025-12-01 | LUNG | Sung Derrick | COO, CFO | A - Grant | $0.00 | +1.20M | 1.34M | +887% | $0 |
| M | 2025-09-03 | 2025-09-02 | LUNG | Williamson Steven S. | Pres AND CEO, Dir | S - Sale | $1.60 | -9,648 | 363.5K | -3% | -$15.4K |
| M | 2025-09-03 | 2025-09-02 | LUNG | Rose Geoffrey Beran | Chief COMMERCIAL Off | S - Sale | $1.60 | -6,543 | 383.8K | -2% | -$10.5K |
| M | 2025-09-03 | 2025-09-02 | LUNG | Lehman David Aaron | GC | S - Sale | $1.60 | -9,769 | 272.1K | -3% | -$15.6K |
| M | 2025-09-03 | 2025-09-02 | LUNG | Joshi Mehul | CFO, PAO | S - Sale | $1.60 | -7,936 | 208.5K | -4% | -$12.7K |
| 2025-06-13 | 2025-06-12 | LUNG | Ferrari Richard | Dir | S - Sale | $3.16 | -8,000 | 87.0K | -8% | -$25.3K | |
| 2025-06-05 | 2025-06-05 | LUNG | Florin Daniel P | Dir | P - Purchase | $3.06 | +23.3K | 117.2K | +25% | +$71.4K | |
| 2025-06-04 | 2025-06-02 | LUNG | Florin Daniel P | Dir | A - Grant | $0.00 | +37.2K | 93.9K | +65% | $0 | |
| M | 2025-06-04 | 2025-06-02 | LUNG | Lehman David Aaron | GC | S - Sale | $3.13 | -10.5K | 278.4K | -4% | -$32.7K |
| M | 2025-06-04 | 2025-06-02 | LUNG | Joshi Mehul | CFO, PAO | S - Sale | $3.13 | -8,061 | 213.9K | -4% | -$25.2K |
| 2025-06-04 | 2025-06-02 | LUNG | Burns Thomas William | Dir | A - Grant | $0.00 | +37.2K | 73.4K | +103% | $0 | |
| 2025-06-04 | 2025-06-02 | LUNG | Ferrari Richard | Dir | A - Grant | $0.00 | +37.2K | 95.0K | +64% | $0 | |
| 2025-06-04 | 2025-06-02 | LUNG | Sullivan Tiffany | Dir | A - Grant | $0.00 | +37.2K | 75.2K | +98% | $0 | |
| 2025-06-04 | 2025-06-02 | LUNG | Mead Dana G Jr. | Dir | A - Grant | $0.00 | +37.2K | 99.7K | +59% | $0 | |
| M | 2025-06-04 | 2025-06-02 | LUNG | Rose Geoffrey Beran | Chief COMMERCIAL Off | S - Sale | $3.13 | -6,947 | 392.2K | -2% | -$21.7K |
| 2025-06-04 | 2025-06-02 | LUNG | French Glendon E. III | Dir | A - Grant | $0.00 | +37.2K | 1.03M | +4% | $0 | |
| 2025-06-04 | 2025-06-02 | LUNG | Melenikiotou Georgia | Dir | A - Grant | $0.00 | +37.2K | 99.7K | +59% | $0 | |
| M | 2025-06-04 | 2025-06-02 | LUNG | Williamson Steven S. | Pres AND CEO, Dir | S - Sale | $3.13 | -9,923 | 366.1K | -3% | -$31.1K |
| 2025-03-21 | 2025-03-20 | LUNG | French Glendon E. III | Dir | S - Sale | $7.85 | -20.0K | 992.0K | -2% | -$157.0K | |
| M | 2025-03-05 | 2025-03-03 | LUNG | Lehman David Aaron | GC | S - Sale | $7.65 | -22.4K | 196.0K | -10% | -$170.9K |
| 2025-03-05 | 2025-03-03 | LUNG | Lehman David Aaron | GC | A - Grant | $0.00 | +108.0K | 283.5K | +62% | $0 | |
| D | 2025-03-05 | 2025-03-03 | LUNG | Williamson Steven S. | Pres AND CEO, Dir | A - Grant | $0.00 | +181.7K | 376.0K | +93% | $0 |
| D | 2025-03-05 | 2025-03-03 | LUNG | Williamson Steven S. | Pres AND CEO, Dir | S - Sale | $7.14 | -27.7K | 194.3K | -12% | -$197.7K |
| M | 2025-03-05 | 2025-03-03 | LUNG | Rose Geoffrey Beran | Chief COMMERCIAL Off | S - Sale | $7.13 | -5,779 | 290.5K | -2% | -$41.2K |
| 2025-03-05 | 2025-03-03 | LUNG | Rose Geoffrey Beran | Chief COMMERCIAL Off | A - Grant | $0.00 | +108.0K | 393.3K | +38% | $0 | |
| 2025-03-05 | 2025-03-03 | LUNG | Joshi Mehul | CFO, PAO | S - Sale | $7.12 | -14.4K | 114.0K | -11% | -$102.4K | |
| 2025-03-05 | 2025-03-03 | LUNG | Joshi Mehul | CFO, PAO | A - Grant | $0.00 | +108.0K | 222.0K | +95% | $0 | |
| M | 2025-02-24 | 2025-02-20 | LUNG | French Glendon E. III | Dir | S - Sale | $8.28 | -55.5K | 1.01M | -5% | -$459.1K |
| M | 2025-01-21 | 2025-01-16+ | LUNG | French Glendon E. III | Dir | S - Sale | $6.52 | -4,547 | 1.07M | -0.4% | -$29.6K |
| M | 2024-12-04 | 2024-12-02 | LUNG | Rose Geoffrey Beran | Chief COMMERCIAL Off | S - Sale | $6.18 | -4,376 | 294.4K | -1% | -$27.1K |
| M | 2024-12-04 | 2024-12-02 | LUNG | Lehman David Aaron | GC | S - Sale | $6.19 | -5,497 | 202.9K | -3% | -$34.0K |
| 2024-11-26 | 2024-11-22 | LUNG | French Glendon E. III | Dir | S - Sale | $6.63 | -20.0K | 1.07M | -2% | -$132.6K | |
| 2024-10-21 | 2024-10-17 | LUNG | French Glendon E. III | Dir | S - Sale | $6.52 | -20.0K | 1.09M | -2% | -$130.4K | |
| 2024-09-18 | 2024-09-12 | LUNG | French Glendon E. III | Dir | S - Sale | $8.09 | -20.0K | 1.11M | -2% | -$161.8K | |
| M | 2024-09-05 | 2024-09-03 | LUNG | Rose Geoffrey Beran | Chief COMMERCIAL Off | S - Sale | $6.70 | -4,586 | 297.0K | -2% | -$30.7K |
| M | 2024-09-05 | 2024-09-03 | LUNG | Lehman David Aaron | GC | S - Sale | $6.69 | -5,765 | 203.3K | -3% | -$38.6K |
| 2024-08-22 | 2024-08-20 | LUNG | Williamson Steven S. | Pres AND CEO, Dir | P - Purchase | $6.84 | +14.2K | 219.5K | +7% | +$97.4K | |
| 2024-06-26 | 2024-06-24 | LUNG | Rose Geoffrey Beran | Chief COMMERCIAL Off | S - Sale | $6.16 | -1,184 | 300.0K | -0.4% | -$7,293 | |
| 2024-06-05 | 2024-06-03 | LUNG | Burns Thomas William | Dir | A - Grant | $0.00 | +15.2K | 36.2K | +72% | $0 | |
| 2024-06-05 | 2024-06-03 | LUNG | Melenikiotou Georgia | Dir | A - Grant | $0.00 | +15.2K | 62.6K | +32% | $0 | |
| 2024-06-05 | 2024-06-03 | LUNG | Ferrari Richard | Dir | A - Grant | $0.00 | +15.2K | 57.9K | +36% | $0 | |
| 2024-06-05 | 2024-06-03 | LUNG | Sullivan Tiffany | Dir | A - Grant | $0.00 | +15.2K | 38.0K | +67% | $0 | |
| M | 2024-06-05 | 2024-06-03 | LUNG | Lehman David Aaron | GC | S - Sale | $6.97 | -5,475 | 214.2K | -2% | -$38.2K |
| M | 2024-06-05 | 2024-06-03 | LUNG | Rose Geoffrey Beran | Chief COMMERCIAL Off | S - Sale | $6.97 | -4,297 | 305.1K | -1% | -$30.0K |
| 2024-06-05 | 2024-06-03 | LUNG | Florin Daniel P | Dir | A - Grant | $0.00 | +15.2K | 41.0K | +59% | $0 | |
| 2024-06-05 | 2024-06-03 | LUNG | Mead Dana G Jr. | Dir | A - Grant | $0.00 | +15.2K | 62.6K | +32% | $0 | |
| 2024-06-05 | 2024-06-03 | LUNG | French Glendon E. III | Dir | A - Grant | $0.00 | +15.2K | 1.13M | +1% | $0 | |
| 2024-05-23 | 2024-05-22 | LUNG | Rose Geoffrey Beran | Chief COMMERCIAL Off | S - Sale | $8.71 | -1,184 | 305.5K | -0.4% | -$10.3K | |
| D | 2024-05-07 | 2024-05-06 | LUNG | Joshi Mehul | CFO, PAO | A - Grant | $0.00 | +125.9K | 125.9K | New | $0 |
| 2024-04-24 | 2024-04-22 | LUNG | Rose Geoffrey Beran | Chief COMMERCIAL Off | S - Sale | $7.49 | -1,184 | 306.7K | -0.4% | -$8,868 | |
| 2024-03-26 | 2024-03-22 | LUNG | Rose Geoffrey Beran | Chief COMMERCIAL Off | S - Sale | $9.36 | -1,184 | 307.9K | -0.4% | -$11.1K | |
| D | 2024-03-19 | 2024-03-15 | LUNG | Williamson Steven S. | Pres AND CEO, Dir | A - Grant | $0.00 | +205.3K | 205.3K | New | $0 |
| DA | 2024-03-07 | 2024-03-01 | LUNG | McKune John | INTERIM CFO | A - Grant | $0.00 | +28.8K | 76.2K | +61% | $0 |
| DA | 2024-03-07 | 2024-03-01 | LUNG | Rose Geoffrey Beran | Chief COMMERCIAL Off | A - Grant | $0.00 | +69.1K | 309.1K | +29% | $0 |
| DA | 2024-03-07 | 2024-03-01 | LUNG | Lehman David Aaron | GC | A - Grant | $0.00 | +69.1K | 214.6K | +47% | $0 |
| DM | 2024-03-05 | 2024-03-01 | LUNG | McKune John | INTERIM CFO | S - Sale | $9.06 | -1,078 | 47.4K | -2% | -$9,767 |
| D | 2024-03-05 | 2024-03-01 | LUNG | McKune John | INTERIM CFO | A - Grant | $0.00 | +14.4K | 61.8K | +30% | $0 |
| M | 2024-03-05 | 2024-03-01 | LUNG | French Glendon E. III | Pres AND CEO, Dir | S - Sale | $9.06 | -6,954 | 1.12M | -0.6% | -$63.0K |
| D | 2024-03-05 | 2024-03-01 | LUNG | Rose Geoffrey Beran | Chief COMMERCIAL Off | A - Grant | $0.00 | +34.5K | 274.5K | +14% | $0 |
| DM | 2024-03-05 | 2024-03-01 | LUNG | Rose Geoffrey Beran | Chief COMMERCIAL Off | S - Sale | $9.06 | -3,097 | 242.6K | -1% | -$28.1K |
| DM | 2024-03-05 | 2024-03-01 | LUNG | Lehman David Aaron | GC | S - Sale | $9.06 | -4,351 | 149.4K | -3% | -$39.4K |
| D | 2024-03-05 | 2024-03-01 | LUNG | Lehman David Aaron | GC | A - Grant | $0.00 | +34.5K | 180.0K | +24% | $0 |
| 2024-02-26 | 2024-02-22 | LUNG | Rose Geoffrey Beran | Chief COMMERCIAL Off | S - Sale | $14.20 | -1,184 | 243.0K | -0.5% | -$16.8K | |
| 2024-02-16 | 2024-02-15 | LUNG | French Glendon E. III | Pres AND CEO, Dir | S - Sale | $14.60 | -20.0K | 1.12M | -2% | -$292.0K | |
| 2024-01-24 | 2024-01-22 | LUNG | Rose Geoffrey Beran | Chief COMMERCIAL Off | S - Sale | $13.13 | -1,184 | 244.2K | -0.5% | -$15.5K | |
| 2024-01-22 | 2024-01-18 | LUNG | French Glendon E. III | Pres AND CEO, Dir | S - Sale | $12.77 | -10.0K | 1.14M | -0.9% | -$127.7K | |
| 2023-12-27 | 2023-12-22 | LUNG | Rose Geoffrey Beran | Chief Commercial Off | S - Sale | $12.75 | -1,184 | 245.4K | -0.5% | -$15.1K | |
| 2023-12-22 | 2023-12-21 | LUNG | French Glendon E. III | Pres, CEO, Dir | S - Sale | $12.42 | -10.0K | 1.15M | -0.9% | -$124.2K | |
| M | 2023-12-05 | 2023-12-01 | LUNG | Lehman David Aaron | GC | S - Sale | $10.34 | -3,809 | 152.5K | -2% | -$39.4K |
| M | 2023-12-05 | 2023-12-01 | LUNG | Rose Geoffrey Beran | Chief Commercial Off | S - Sale | $10.34 | -2,868 | 246.6K | -1% | -$29.7K |
| M | 2023-12-05 | 2023-12-01 | LUNG | McKune John | Interim CFO | S - Sale | $10.34 | -942 | 40.4K | -2% | -$9,739 |
| 2023-12-05 | 2023-12-01 | LUNG | McKune John | Interim CFO | A - Grant | $0.00 | +7,233 | 47.6K | +18% | $0 | |
| M | 2023-12-05 | 2023-12-01 | LUNG | French Glendon E. III | Pres, CEO, Dir | S - Sale | $10.34 | -6,676 | 1.17M | -0.6% | -$69.0K |
| 2023-11-27 | 2023-11-22 | LUNG | Rose Geoffrey Beran | Chief Commercial Off | S - Sale | $10.60 | -1,184 | 249.5K | -0.5% | -$12.6K |
Purchase Sale Sale after option exercise All abbreviations